Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
None
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

for PsO. Ixekizumab is a humanized immunoglobulin G4 (IgG4 kappa) monoclonal antibody targeting interleukin (IL)-17A. It is highly efficacious in the treatment of plague PsO with and favorable

  • 0 views
  • 09 Jul, 2021
  • 1 location
None
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

15 patients with PRP will be treated with guselkumab for 20 weeks to determine safety and efficacy. Participants are required to travel to Portland, OR only for the first visit, week-4 visit, and week-24 visit. 3 visits in between these times and one follow up visit may be performed by …

  • 28 views
  • 07 Mar, 2021
  • 1 location
None
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

The reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA

arthritis
  • 0 views
  • 24 Oct, 2021
  • 49 locations
None
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score

  • 10 views
  • 10 Sep, 2021
  • 1 location
None
Assessing Patient Confidence in Biologic Medications

), interleukin 12/23 blockers (ustekinumab) and interleukin 17A blockers (secukinumab, ixekizumab). Due to biologic medication's efficacy and safety profiles, they have revolutionized dermatology and the

etanercept
certolizumab pegol
tumor necrosis factor
tumor necrosis factor alpha
infliximab
  • 67 views
  • 09 Sep, 2021
  • 1 location